Navtemadlin
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Navtemadlin, covering 2023-03-02 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia [Phase 1]